LONDON - Celltech Group plc has refused to comment on reports that it is preparing to make a cash bid for Oxford GlycoSciences plc, undermining the agreed-to all-share takeover offer made by Cambridge Antibody Technology Group plc on Jan. 23. (BioWorld International)

LONDON - The charity Cancer Research UK launched a £500,000 (US$814,000) research program to use RNA interference technology to systematically uncover the function of all human genes, with the ultimate aim of identifying all genes involved in cancer that would be good drug targets. (BioWorld International)

LONDON - The charity Cancer Research UK launched a £500,000 (US$814,000) research program to use RNA interference technology to systematically uncover the function of all human genes, with the ultimate aim of identifying all genes involved in cancer that would be good drug targets. (BioWorld International)